THE CCK ANTAGONIST PROGLUMIDE FAILS TO ANTAGONIZE THE SATIATING EFFECT OF AN ORALLY INGESTED PRELOAD

被引:0
|
作者
SCHNEIDER, LH [1 ]
GIBBS, J [1 ]
SMITH, GP [1 ]
机构
[1] CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021
关键词
D O I
暂无
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
引用
收藏
页码:298 / 299
页数:2
相关论文
共 10 条
  • [1] PROGLUMIDE FAILS TO INCREASE FOOD-INTAKE AFTER AN INGESTED PRELOAD
    SCHNEIDER, LH
    GIBBS, J
    SMITH, GP
    PEPTIDES, 1986, 7 (01) : 135 - 140
  • [2] PROGLUMIDE BLOCKS THE SATIATING EFFECT OF EXOGENOUS CCK-8 BUT NOT OF INTRADUODENAL FAT INFUSIONS IN ZUCKER RATS
    GREENBERG, D
    GIBBS, J
    SMITH, GP
    APPETITE, 1986, 7 (03) : 263 - 263
  • [3] EFFECT OF CHOLECYSTOKININ (CCK) ANTAGONIST, PROGLUMIDE, ON CCK-8-INDUCED GALLBLADDER CONTRACTION IN CONSCIOUS DOGS
    FUJIMURA, M
    BEAUCHAMP, RD
    LLUIS, F
    SAKAMOTO, T
    TOWNSEND, CM
    THOMPSON, JC
    GASTROENTEROLOGY, 1985, 88 (05) : 1389 - 1389
  • [4] THE EFFECT OF A CCK ANTAGONIST, PROGLUMIDE, ON THE GASTROCOLIC MOTOR RESPONSE IN HEALTHY-HUMAN SUBJECTS
    SHANNON, S
    REDDY, N
    WATERFALL, W
    CAMPBELL, D
    GOODACRE, R
    COLLINS, S
    GASTROENTEROLOGY, 1986, 91 (04) : 1067 - 1067
  • [5] EFFECT OF PROGLUMIDE, A GASTRIN CCK RECEPTOR ANTAGONIST ON GASTRIC-ACID AND PANCREATIC-ENZYME SECRETION INVIVO
    LOEWE, CJ
    GRIDER, JR
    VLAHCEVIC, ZR
    GASTROENTEROLOGY, 1983, 84 (05) : 1232 - 1232
  • [6] EFFECT OF PROGLUMIDE, A CCK RECEPTOR ANTAGONIST, ON CAERULEIN-INDUCED PANCREATIC-ENZYME SECRETION AND PLASMA PP RELEASE
    FRIED, M
    BEGLINGER, C
    WHITEHOUSE, I
    GYR, K
    DIGESTION, 1983, 28 (01) : 28 - 28
  • [7] EFFECT OF PROGLUMIDE, A CCK-RECEPTOR ANTAGONIST, ON CAERULEIN-INDUCED PANCREATIC-ENZYME SECRETION AND PLASMA-PP RELEASE
    FRIED, M
    BEGLINGER, C
    WHITEHOUSE, I
    GYR, K
    DIGESTIVE DISEASES AND SCIENCES, 1983, 28 (10) : 934 - 934
  • [8] Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro
    Daisuke Kawasaki
    Yutaka Emori
    Runa Eta
    Yuka Iino
    Hiroki Hamano
    Koji Yoshinaga
    Takao Tanaka
    Mineo Takei
    Susan A. Watson
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 883 - 892
  • [9] Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro
    Kawasaki, Daisuke
    Emori, Yutaka
    Eta, Runa
    Iino, Yuka
    Hamano, Hiroki
    Yoshinaga, Koji
    Tanaka, Takao
    Takei, Mineo
    Watson, Susan A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 883 - 892
  • [10] Inhibitory effect of Z-360, a novel, orally active CCK-2/Gastrin receptor antagonist, on gastrin-17-induced proliferation, Pkb/Akt phosphorylation and in vivo growth of human pancreatic adenocarcinoma cell lines
    Emori, Yutaka
    Kawasaki, Daisuke
    Eta, Runa
    Iino, Yuka
    Hamano, Hiroki
    Yoshmaga, Koji
    Tanaka, Takao
    Takei, Mineo
    Watsori, Susan A.
    GASTROENTEROLOGY, 2007, 132 (04) : A433 - A434